Back to Search Start Over

Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study

Authors :
Shuai Wang
Yifei Huang
Weiling Hu
Hua Mao
Mark Edward McAlindon
Yanna Liu
Li Yang
Chunqing Zhang
Ming Xu
Chaohui He
Tong Dang
Bin Wu
Dong Ji
Liting Zhang
Xiaorong Mao
Lei Zhang
Chuan Liu
Dan Xu
Yasong Li
Guoan Li
Juqiang Han
Fangfang Lv
Xiao Liang
Shaoqin Jin
Shaoheng Zhang
Foong Way David Tai
Qing Xu
Changqing Yang
Guangchuan Wang
Lifen Wang
Bo Li
Haiyun Yang
Ping Xie
Lulin Deng
Limei Ren
Zhiheng Chang
Xing Wang
Shan Wang
Xiaoqin Gao
Junfeng Li
Longdong Zhu
Fangzhao Wang
Lingen Zhang
Guo Zhang
Xi Jiang
Jun Pan
Wenbo Meng
Xun Li
Jinlin Hou
Xavier Dray
Zhuan Liao
Xiaolong Qi
Source :
The Lancet Regional Health. Western Pacific, Vol 6, Iss , Pp 100072- (2021)
Publication Year :
2021
Publisher :
Elsevier, 2021.

Abstract

Background: Gastroesophageal varices is a serious complication of compensated advanced chronic liver disease (cACLD). Primary prophylaxis to reduce the risk of variceal hemorrhage is recommended if high-risk varices (HRV) are detected. We performed this study to compare the accuracy, patients’ satisfaction and safety of detection of HRV by detachable string magnetically controlled capsule endoscopy (DS-MCCE) with esophagogastroduodenoscopy (EGD) as the reference. Methods: We prospectively recruited participants with cACLD from 12 university hospitals (11 in China and one in the United Kingdom) between November 2018 and December 2019 (ClinicalTrials.gov, NCT03749954). All participants underwent DS-MCCE, followed by EGD within a week in a blinded fashion. Following endoscopy, and on the same day, participants were asked to fill in a satisfaction questionnaire regarding their experience. Findings: A total of 105 eligible participants were enrolled. With EGD as the reference standard, the concordance index, sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio of DS-MCCE in diagnosis of HRV were 0•90 (95% confidence interval [CI]: 0•83–0•95), 92% (95% CI: 78–98%), 88% (95% CI: 78–95%), 80% (95% CI: 70–92%), 95% (95% CI: 90–100%), 7•91 (95% CI: 4•10–15•30), and 0•09 (95% CI: 0•03–0•30), respectively. The kappa score of 0•78 (95% CI: 0•65–0•90) suggested substantial agreement between DS-MCCE and EGD. Moreover, in participants undergoing EGD without sedation, the satisfaction of DS-MCCE was significantly better than that of EGD (p < 0•0001, d = 1•15 [95%CI: 0•88–1•42]). All participants confirmed the excretion of the capsule, and no adverse events occurred. Interpretation: DS-MCCE is an accurate alternative to EGD for detecting HRV in cACLD, which is safe and associated with better satisfaction. Funding: A full list of funding can be found in the Funding Support section.

Details

Language :
English
ISSN :
26666065
Volume :
6
Issue :
100072-
Database :
Directory of Open Access Journals
Journal :
The Lancet Regional Health. Western Pacific
Publication Type :
Academic Journal
Accession number :
edsdoj.6f07bb19be75415fb0aed842d24bf34c
Document Type :
article
Full Text :
https://doi.org/10.1016/j.lanwpc.2020.100072